|
Thursday, 23 April 2009 13:05 |
|
Download pdf |
|
Thursday, 23 April 2009 13:03 |
|
Download pdf |
|
Wednesday, 08 April 2009 14:52 |
We have published new guidance on the requirements for authorisation for prospective developers of radioactive waste disposal facilities.
Both guidance documents apply the same principles and (largely) the same detailed requirements. We expect developers or operators to interpret the requirements in a way that is proportionate to the hazard presented by the waste disposed of to the facility.
Our guidance sets high standards to help us and industry protect people’s health and deliver the best outcome for the environment.
For more information see our website
|
|
Wednesday, 08 April 2009 14:11 |
Medicare Coverage Decision Memo for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R)
CMS was asked to reconsider Section 220.6 of the National Coverage Determination (NCD) Manual to end the prospective data collection requirements across all oncologic indications of FDG PET except for monitoring response to treatment. Section 220.6 of the NCD Manual established the requirement for prospective data collection for FDG PET used in the diagnosis, staging, restaging and monitoring response to treatment for brain, cervical, ovarian, pancreatic, small cell lung and testicular cancers, as well as for cancer indications not previously specified in Section 220.6 in its entirety.
link |
